thymidine has been researched along with Adenoma, Prolactin-Secreting, Pituitary in 4 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "Human pituitary adenoma cells and rat pituitary cell line (GH3) were cultured and treated in vitro with octreotide and the broad-spectrum SST agonist SOM230 (pasireotide)." | 3.73 | Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours. ( Ciccarelli, E; Czirják, S; Gaia, D; Góth, MI; Grossman, AB; Hanson, MR; Hanzély, Z; Hubina, E; Jordan, S; Khalaf, S; Korbonits, M; Losa, M; Nagy, GM; Nanzer, AM; Papotti, M; Terreni, MR, 2006) |
| "Bromocriptine (BC) is a well known anti-neoplasic agent in human PRL secreting adenomas although its effect on PRL cells is far from clear." | 1.31 | Bromocriptine and the expression of c-myc and c-fos in human prolactinomas. ( Basso, A; Burdman, JA; Calabrese, MT; Guerra, LN, 2001) |
| "The most effective therapy of human prolactinomas is represented by dopamine D-2 receptor agonists; there is, however, a population of nonresponder patients who require surgical intervention." | 1.29 | Nerve growth factor suppresses the transforming phenotype of human prolactinomas. ( Balsari, A; Boroni, F; Dal Toso, R; Giovanelli, M; Losa, M; Missale, C; Spano, P; Zanellato, A, 1993) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (50.00) | 18.2507 |
| 2000's | 2 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Hubina, E | 1 |
| Nanzer, AM | 1 |
| Hanson, MR | 1 |
| Ciccarelli, E | 1 |
| Losa, M | 2 |
| Gaia, D | 1 |
| Papotti, M | 1 |
| Terreni, MR | 1 |
| Khalaf, S | 1 |
| Jordan, S | 1 |
| Czirják, S | 1 |
| Hanzély, Z | 1 |
| Nagy, GM | 1 |
| Góth, MI | 1 |
| Grossman, AB | 1 |
| Korbonits, M | 1 |
| Missale, C | 1 |
| Boroni, F | 1 |
| Giovanelli, M | 1 |
| Zanellato, A | 1 |
| Dal Toso, R | 1 |
| Balsari, A | 1 |
| Spano, P | 1 |
| Díaz-Torga, G | 1 |
| González Iglesias, A | 1 |
| Achával-Zaia, R | 1 |
| Libertun, C | 1 |
| Becú-Villalobos, D | 1 |
| Burdman, JA | 1 |
| Guerra, LN | 1 |
| Calabrese, MT | 1 |
| Basso, A | 1 |
4 other studies available for thymidine and Adenoma, Prolactin-Secreting, Pituitary
| Article | Year |
|---|---|
Somatostatin analogues stimulate p27 expression and inhibit the MAP kinase pathway in pituitary tumours.
Topics: Adenoma; Animals; Antineoplastic Agents, Hormonal; Cell Division; Cell Line, Tumor; Cyclin-Dependent | 2006 |
Nerve growth factor suppresses the transforming phenotype of human prolactinomas.
Topics: Animals; Binding, Competitive; Bromocriptine; Cell Division; Cell Membrane; Humans; Kinetics; Mice; | 1993 |
Angiotensin II-induced Ca2+ mobilization and prolactin release in normal and hyperplastic pituitary cells.
Topics: Angiotensin II; Animals; Calcium; Cells, Cultured; DNA Replication; Estrogens; Female; Hyperplasia; | 1998 |
Bromocriptine and the expression of c-myc and c-fos in human prolactinomas.
Topics: Adult; Antineoplastic Agents; Bromocriptine; Cell Division; DNA; DNA Replication; Dopamine Agonists; | 2001 |